YHYuko Horiba

Yuko Horiba

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuko Horiba has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of Ninjin’yoeito in Alleviating Fatigue after Gynecological Cancer Treatment: An Observational Study

    by Yuko Horiba, Misa Akita, Tetsuhiro Yoshino, Megumi Yokota, Hiroshi Nishio, Aya Jibiki, Tomonori Nakamura, Takashi Iwata, Kenji Watanabe, Koichi Fukunaga, et al.

  • Open Access

    Authors' Reply: Conceptual Translation and Patient Safety in the Cross‐Cultural Transfer of Kampo Medicine

    by Yonatan Klein, Tetsuhiro Yoshino, Yuko Horiba, Yuzo Ishii, Ryutaro Arita, Natsumi Saito, Akiko Kikuchi, Akira Kaneko, Kazushi Uneda, Shin Takayama, et al.

  • Open Access

    The Journey of Studying Kampo Medicine in Japan Through the Eyes of an Israeli Acupuncturist and Kampo Practitioner

    by Yonatan Klein, Tetsuhiro Yoshino, Yuko Horiba, Yuzo Ishii, Ryutaro Arita, Natsumi Saito, Akiko Kikuchi, Akira Kaneko, Kazushi Uneda, Shin Takayama, et al.

    Objective: To highlight the stark contrasts in the integration, regulation, and practice of traditional medicine between the two countries (Israel and Japan). Methods: This article chronicles the personal and professional journey of an Israeli acupuncturist studying Kampo medicine in Japan. Through personal experience as a visiting researcher at Keio University Hospital, Tohoku University Hospital, and Fukushima Medical University Aizu Medical Center, this paper reports on the observed systematic approach of Kampo, including the diagnostic method of Fukushin (abdominal diagnosis) and discusses the challenges and opportunities for non‐physicians seeking to study this field in Japan. Results: While Traditional Chinese Medicine ( TCM ) in Israel is primarily practiced in private clinics with limited governmental regulation, Kampo medicine in Japan is formally integrated into the national healthcare system, covered by insurance, and taught in all medical schools. Additionally, the clinical utility of Fukushin was observed, and significant challenges for non‐physicians studying Kampo in Japan were identified. Conclusion: The author's journey underscores the institutional legitimacy of Kampo and suggests a path toward fostering a greater exchange between Israeli TCM and Japanese Kampo, bridging two traditions that are similar in origin yet vastly different in their modern application and recognition. To address the challenges for non‐physicians, establishing short‐term clinical observation programs is proposed as a concrete solution.


  • Open Access

    Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational study

    by Ayako Rph Maeda-Minami, Ayako Rph Kawamoto, Tetsuhiro Yoshino, Yuta Rph Yokoyama, Sayo Rph Suzuki, Yuko Horiba, Tomonori Rph Nakamura, Masaru Mimura, Kenji Watanabe

    Two representative Kampo formulas, keishibukuryogan and tokishakuyakusan, are frequently prescribed for patients with dysmenorrhea. We previously constructed a model that could predict which of these 2 formulas was most suitable, which is based on 4 subjective symptoms and 3 objective signs. To evaluate the prognosis of patients with dysmenorrhea using the established prediction model and assess the treatment outcomes between those treated in accordance with the prediction model and those who received various other treatments. In this retrospective, observational study, we included patients with menstrual pain who visited the Kampo Clinic at the Keio University Hospital for the first time between October 2014 and December 2020. These patients were monitored over a 90-day follow-up period. Participants were categorized into 2 groups: model-accordance and various-options. The progression of visual analogue scale (VAS) values was evaluated by determining the slopes from regression analysis between these 2 groups, with changes corroborated by the medical records. The study comprised 57 patients: 37 in the model-accordance group and 20 in the various-options group. Notably, the various-options group reported a significantly higher number of subjective symptoms (P = .03). The VAS value showed a decline, as indicated by the negative slope value of the regression line, across both groups – irrespective of their classification. There were no significant differences in the occurrence of adverse events between the 2 groups. The prognosis of patients with dysmenorrhea and the incidence of adverse events remained consistent, regardless of whether the treatment approach was in accordance with the prediction model or varied. Further studies are warranted to assess the prognosis when Kampo formulas are chosen based on the prediction model in the various-options population.


  • Open Access

    A prediction model of qi stagnation: A prospective observational study referring to two existing models

    by Ayako Maeda-Minami, Keiko Ihara, Tetsuhiro Yoshino, Yuko Horiba, Masaru Mimura, Kenji Watanabe


  • Open Access

    Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study

    by Yuko Horiba, Tetsuhiro Yoshino, Megumi Yokota, Takashi Iwata, Kenji Watanabe, Masaru Mimura, Daisuke Aoki

    Purpose: To date, no studies have assessed climacteric symptoms after hystero-adnexectomy for endometrial, cervical, or ovarian cancer. Thus, this study aimed to compare climacteric symptoms among patients who underwent surgery for these three cancer types. Methods: In this cross-sectional study, we interviewed patients who were registered at a menopausal outpatient clinic between January 1999 and July 2016 after undergoing total hysterectomy, intrapelvic only or intrapelvic plus para-aortic lymph node dissection, and bilateral adnexectomy performed via laparotomy as a cancer treatment. Climacteric symptoms were assessed using a patient-reported questionnaire covering core domains with five symptoms only at the initial consultation. Each symptom was graded from 0 (no symptoms) to 3 (severe symptoms). We evaluated the frequency of symptom severity according to the time elapsed since surgery and the cancer type. Results: The numbers of patients with endometrial, ovarian, and cervical cancer were 328, 90, and 107, respectively. Overall, climacteric symptoms were more severe in patients with cervical cancer than in those with endometrial or ovarian cancer; symptom severity decreased with increasing time since surgery. However, symptom severity did not decrease significantly over time in patients with cervical cancer even after > 5 years had elapsed since surgery. Conclusion: The climacteric symptoms were less severe in patients with endometrial or ovarian cancer with longer time elapsed since surgery but not in those with cervical cancer. Patients with cervical cancer may require more prompt interventions, including symptomatic treatment and longer follow-up period, than those with endometrial or ovarian cancer.


  • Open Access

    Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study

    by Yuko Horiba, Tetsuhiro Yoshino, Megumi Yokota, Takashi Iwata, Kenji Watanabe, Masaru Mimura, Daisuke Aoki

    Background: No studies have assessed climacteric symptoms after hystero-adnexectomy for endometrial, cervical, or ovarian cancer. Thus, this study aimed to compare climacteric symptoms among patients who underwent surgery for these three cancer types.Methods: We included patients who were registered at a menopausal outpatient clinic between January 1999 and July 2016 after undergoing total hysterectomy, intrapelvic only or intrapelvic plus para-aortic lymph node dissection, and bilateral adnexectomy performed via laparotomy as cancer treatment. Climacteric symptoms were assessed using a patient-reported questionnaire covering core domains with five symptoms. Each symptom was graded from 0 (no symptoms) to 3 (severe symptoms). We evaluated the frequency of this symptom severity by time elapsed since surgery and cancer type.Results: The numbers of patients with endometrial, ovarian, and cervical cancer were 328, 90, and 107, respectively. Overall, climacteric symptoms were more severe in patients with cervical cancer than in those with endometrial or ovarian cancer; symptom severity decreased with increasing time since surgery. However, symptom severity did not decrease significantly over time in patients with cervical cancer even after >5 years had elapsed since surgery.Conclusions: The severity of climacteric symptoms decreased with the time elapsed since surgery for patients with endometrial or ovarian cancer but not for those with cervical cancer. Patients with cervical cancer may require more prompt interventions, including symptomatic treatment and longer follow-up, than those with endometrial or ovarian cancer.

  • Open Access

    Climacteric Symptoms in Postoperative Patients Among Endometrial Cancer, Cervical Cancer, and Ovarian Cancer: A Cross-Sectional Study

    by Yuko Horiba, Tetsuhiro Yoshino, Megumi Yokota, Takashi Iwata, Kenji Watanabe, Masaru Mimura, Daisuke Aoki

    Background: No studies have assessed climacteric symptoms after hystero-adnexectomy for endometrial, cervical, or ovarian cancer. Thus, this study aimed to compare climacteric symptoms among patients who underwent surgery for these three cancer types.Methods: We included patients who were registered at a menopausal outpatient clinic between January 1999 and July 2016 after undergoing total hysterectomy, intrapelvic only or intrapelvic plus para-aortic lymph node dissection, and bilateral adnexectomy performed via laparotomy as cancer treatment. The numbers of patients with endometrial, ovarian, and cervical cancer were 328, 90, and 107, respectively. We collected the following data: age at surgery, time since surgery, body mass index, menopausal status at surgery, and postoperative adjuvant therapy. Climacteric symptoms were assessed using a patient-reported questionnaire covering 40 parameters. Each symptom was graded from 0 (no symptoms) to 3 (severe symptoms). The total for all 40 parameters was considered as the degree of symptom severity.Results: Multivariate analysis revealed that time since surgery and cancer type had statistically significant effects on climacteric symptom severity. Overall, climacteric symptoms were more severe in patients with cervical cancer than in those with endometrial or ovarian cancer; symptom severity decreased with increasing time since surgery. However, in patients with cervical cancer, symptom severity did not decrease significantly over time, even after >5 years had elapsed since surgery.Conclusions: The severity of climacteric symptoms decreased with time after surgery for patients with endometrial or ovarian cancer but not for those with cervical cancer. Patients with cervical cancer may require more prompt interventions, including symptomatic treatment, and longer follow-up than those with endometrial or ovarian cancer.

  • Discrimination of prediction models between cold-heat and deficiency-excess patterns

    by Ayako Maeda-Minami, Tetsuhiro Yoshino, Kotoe Katayama, Yuko Horiba, Hiroaki Hikiami, Yutaka Shimada, Takao Namiki, Eiichi Tahara, Kiyoshi Minamizawa, Shinichi Muramatsu, et al.


  • Prediction of deficiency-excess pattern in Japanese Kampo medicine: Multi-centre data collection

    by Ayako Maeda-Minami, Tetsuhiro Yoshino, Kotoe Katayama, Yuko Horiba, Hiroaki Hikiami, Yutaka Shimada, Takao Namiki, Eiichi Tahara, Kiyoshi Minamizawa, Shinichi Muramatsu, et al.